# Sea buckthorn berry extract favorably affects bone metabolism-related biomarkers and collagen deposition in cultured rat primary osteoblasts

**Authors:** Monika Martiniakova, Vladimira Mondockova, Anna Sarocka, Noemi Penzes, Veronika Kovacova, Roman Biro, Natalia Slawinska, Beata Olas, Radoslav Omelka

PMC · DOI: 10.1515/biol-2025-1288 · 2026-02-23

## TL;DR

Sea buckthorn extract improves bone-related markers in rat osteoblasts, suggesting potential as a bone health supplement.

## Contribution

The study demonstrates that sea buckthorn extract at specific concentrations enhances bone metabolism markers in primary osteoblasts.

## Key findings

- Sea buckthorn extract increased levels of BGLAP, COL1A1, and IBSP at specific concentrations.
- Collagen deposition was enhanced, while TNFSF11 levels were reduced.
- Higher doses reduced cell viability and mineralization despite lowering apoptosis.

## Abstract

This study aimed to analyse the impact of sea buckthorn (SB) berry extract on the function of cultured rat primary osteoblasts, including the production of bone metabolism-related biomarkers and bone matrix formation. Primary osteoblasts best reflect in vivo conditions. Osteoblast apoptosis, viability, alkaline phosphatase (ALPL) activity, production of ALPL, osteocalcin (BGLAP), collagen type I alpha 1 (COL1A1), integrin-binding sialoprotein (IBSP), tumor necrosis factor ligand superfamily member 11 (TNFSF11), and calcium/collagen deposition were assessed. The composition of the extract showed that the main phenolic metabolites found were flavonol glycosides (67.1 %). SB berry extract significantly increased the levels of BGLAP (at 0.5 and 1 μg/mL), COL1A1 (at 1–100 μg/mL), IBSP (at 0.1–1 μg/mL), collagen deposition (at 1–10 μg/mL), and decreased TNFSF11 levels (at 0.1 and 0.5 μg/mL). Although higher doses of the extract (50 and 100 μg/mL) reduced osteoblast apoptosis, they also lowered cell viability, IBSP levels, and mineralization. It can be concluded that SB berry extract at concentrations up to 10 μg/mL favorably affected multiple bone metabolism-related biomarkers, indicating that it has encouraging potential for use as a nutraceutical to support bone health due to the unique composition of bioactive metabolites and the known synergistic interactions between them.

## Linked entities

- **Genes:** ALPL (alkaline phosphatase, biomineralization associated) [NCBI Gene 249], BGLAP (bone gamma-carboxyglutamate protein) [NCBI Gene 632], COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277], IBSP (integrin binding sialoprotein) [NCBI Gene 3381], TNFSF11 (TNF superfamily member 11) [NCBI Gene 8600]
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Ibsp (integrin-binding sialoprotein) [NCBI Gene 24477] {aka Bsp}, Tnfsf11 (tumor necrosis factor (ligand) superfamily, member 11) [NCBI Gene 21943] {aka Ly109l, ODF, OPGL, RANKL, Trance}, Tnfsf11 (TNF superfamily member 11) [NCBI Gene 117516] {aka ODF, OPGL, RANKL, TRANCE}, Bglap (bone gamma-carboxyglutamate protein) [NCBI Gene 25295] {aka Bglap2, Bgp, Bgpr, Bgpra}, Ibsp (integrin binding sialoprotein) [NCBI Gene 15891] {aka BSP, BSP II, BSPII, Bsp2}, Alpl (alkaline phosphatase, liver/bone/kidney) [NCBI Gene 11647] {aka ALP, APTNAP, Akp-2, Akp2, TNAP, TNSALP}, Bglap (bone gamma carboxyglutamate protein) [NCBI Gene 12096] {aka BGP, Bglap1, OC, OG1, mOC-A}, Dntt (DNA nucleotidylexotransferase) [NCBI Gene 294051], Col1a1 (collagen type I alpha 1 chain) [NCBI Gene 29393] {aka COLIA1}, Ahr (aryl-hydrocarbon receptor) [NCBI Gene 11622] {aka Ah, Ahh, Ahre, In, bHLHe76}, Col1a1 (collagen, type I, alpha 1) [NCBI Gene 12842] {aka Col1a-1, Cola-1, Cola1, Mov-13, Mov13}, Alpl (alkaline phosphatase, biomineralization associated) [NCBI Gene 25586] {aka AP-TNAP, Akp2, PHOA, TNAP, TNSALP}
- **Diseases:** cancer (MESH:D009369), bone disease (MESH:D001847), cytotoxicity (MESH:D064420), osteoporosis (MESH:D010024), inflammatory (MESH:D007249), cartilage (MESH:D002357)
- **Chemicals:** dexamethasone (MESH:D003907), beta-glycerophosphate (MESH:C031463), dUTP (MESH:C027078), amino acids (MESH:D000596), Quercetin (MESH:D011794), triterpenes (MESH:D014315), phytosterols (MESH:D010840), streptomycin (MESH:D013307), quercetin glycosides (MESH:D012431), fatty acids (MESH:D005227), Sea buckthorn berry extract (-), picric acid (MESH:C005858), methanol (MESH:D000432), penicillin (MESH:D010406), ascorbic acid (MESH:D001205), isorhamnetin (MESH:C047368), flavonol (MESH:C041477), Flavonoids (MESH:D005419), Alizarin Red S (MESH:C004468), Calcium (MESH:D002118), polyphenol (MESH:D059808), water (MESH:D014867), carotenoids (MESH:D002338), CO2 (MESH:D002245), Kaempferol (MESH:C006552), phenolic acids (MESH:C017616), catechins (MESH:D002392)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Hippophae rhamnoides (sallowthorn, species) [taxon 193516], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** MC3T3-E1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0409), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), C3H10T1/2 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0190)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12924683/full.md

---
Source: https://tomesphere.com/paper/PMC12924683